Assessing endocrine disruption involves a combination of in vitro assays, animal studies, and epidemiological research. Regulatory agencies have developed specific guidelines and tests to evaluate the endocrine-disrupting potential of chemicals. These include examining hormone levels, reproductive outcomes, and developmental markers.
